Research on the Application of Blood Collection Through Midline Catheters of Different Lengths

NCT ID: NCT06014099

Last Updated: 2023-10-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

162 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-27

Study Completion Date

2025-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Therefore, in this study, the investigators propose to use a randomized controlled prospective open study on inpatients with difficult blood collection, by comparing the effects of the application of two types of peripheral venous catheters for blood collection via LPC and MC, with a view to improving the success rate of blood collection in difficult peripheral venous blood collection, and providing a theoretical basis for the later application of long peripheral venous catheters and midline catheters; and providing a basis for optimizing the experience of venous blood collection by nurses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Using block randomization, patients were randomized in 1:1:1 blocks into experimental arm 1(Long peripheral venous catheter), experimental arm 2(midline catheter), and control (short peripheral venous catheter) with a block length of 6. Patients have a total of 27 blocks, import data into SPSS23, randomly group by SPSS, generate random numbers, and group according to the size of random numbers in each unit group, the largest in the group is assigned to the experimental group 1, the middle of the group is assigned to the experimental group 2, and the smallest in the group is assigned to the control group. The experimental group1 used the LPC for blood collection, the experimental group 2 used the MC for blood collection,and the control group used the Short PIVC for blood collection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Catheter Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors
Not possible because of the material and characteristics of the catheter

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Midline catheter

The test group2 used MC for blood collection.

Group Type EXPERIMENTAL

Midline catheter for blood collection

Intervention Type BEHAVIORAL

used MCs for blood collection

Long peripheral venous catheters

In the test 1 group, blood was collected using LPC.

Group Type EXPERIMENTAL

Long peripheral venous catheters for blood collection

Intervention Type BEHAVIORAL

used LPC for blood collection

short peripheral venous catheters

In the control group,blood was collected using SPC.

Group Type OTHER

SPCs for blood collection

Intervention Type BEHAVIORAL

used SPCs for blood collection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Long peripheral venous catheters for blood collection

used LPC for blood collection

Intervention Type BEHAVIORAL

Midline catheter for blood collection

used MCs for blood collection

Intervention Type BEHAVIORAL

SPCs for blood collection

used SPCs for blood collection

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meet the international diagnostic criteria for metabolic syndrome (such as ATP III criteria or domestic Diabetes Branch of Chinese Medical Association criteria).
* The estimated treatment time of intravenous infusion is 1-4 weeks, and the nature of the infusion drug meets the indications of LPCs and MCs.
* Blood samples should be collected more than 3 times during the hospital.

Exclusion Criteria

* A history of radiotherapy, thrombosis, and trauma at the catheter site.
* Plan to discharge from the hospital with the tube.
* Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, illiterate, etc.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sir Run Run Shaw Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhao Linfang

Assitant nursing director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Linfang Zhao

Role: PRINCIPAL_INVESTIGATOR

Sir Run Run Shaw Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Linfang Zhao

Hangzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Linfang Zhao

Role: CONTACT

13588819123

Xiuzhu Cao

Role: CONTACT

13588477316

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Linfang Zhao

Role: primary

13588819123

Xiuzhu Cao

Role: backup

13588477316

References

Explore related publications, articles, or registry entries linked to this study.

Lima-Oliveira G, Lippi G, Salvagno GL, Picheth G, Guidi GC. Laboratory Diagnostics and Quality of Blood Collection. J Med Biochem. 2015 Jul;34(3):288-294. doi: 10.2478/jomb-2014-0043. Epub 2015 Jul 14.

Reference Type BACKGROUND
PMID: 28356839 (View on PubMed)

HO Guidelines Approved by the Guidelines Review Committee[J]. 2015.

Reference Type BACKGROUND

Tsukuda Y, Funakoshi T, Nasuhara Y, Nagano Y, Shimizu C, Iwasaki N. Venipuncture Nerve Injuries in the Upper Extremity From More Than 1 Million Procedures. J Patient Saf. 2019 Dec;15(4):299-301. doi: 10.1097/PTS.0000000000000264.

Reference Type BACKGROUND
PMID: 27314202 (View on PubMed)

Jeong Y, Park H, Jung MJ, Kim MS, Byun S, Choi Y. Comparisons of laboratory results between two blood samplings: Venipuncture versus peripheral venous catheter-A systematic review with meta-analysis. J Clin Nurs. 2019 Oct;28(19-20):3416-3429. doi: 10.1111/jocn.14918. Epub 2019 Jun 10.

Reference Type BACKGROUND
PMID: 31112315 (View on PubMed)

Gorski LA, Hadaway L, Hagle ME, Broadhurst D, Clare S, Kleidon T, Meyer BM, Nickel B, Rowley S, Sharpe E, Alexander M. Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021 Jan-Feb 01;44(1S Suppl 1):S1-S224. doi: 10.1097/NAN.0000000000000396. No abstract available.

Reference Type BACKGROUND
PMID: 33394637 (View on PubMed)

Wicker S, Stirn AV, Rabenau HF, von Gierke L, Wutzler S, Stephan C. Needlestick injuries: causes, preventability and psychological impact. Infection. 2014 Jun;42(3):549-52. doi: 10.1007/s15010-014-0598-0. Epub 2014 Feb 14.

Reference Type BACKGROUND
PMID: 24526576 (View on PubMed)

Zhang Y, Zhang S, Chen J, Zhao R. Blood sampling from peripherally inserted central catheter is effective and safe for patients with head and neck cancers. J Vasc Access. 2021 May;22(3):424-431. doi: 10.1177/1129729820943458. Epub 2020 Aug 3.

Reference Type BACKGROUND
PMID: 32741243 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IV202308

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CVCs Versus Midline Catheters
NCT06884176 NOT_YET_RECRUITING NA